Word

ADAPTIN BIO

Status

Pending

Status Code

630

Status Date

Thursday, September 12, 2024

Serial Number

98746955

Filing Date

Thursday, September 12, 2024

Trademark Owner History

Adaptin Bio, Inc.

Classifications

5 Biological preparations for pharmaceuticals; Biological preparations for treatment of cancers, central nervous system diseases and autoimmune disorders; Medical preparations and pharmaceuticals for treatment of cancers, central nervous system diseases and autoimmune disorders; Drug delivery platform technology, namely, drug delivery agents consisting of cellular products that facilitate, enhance or promote optimized delivery of pharmaceutical therapies; Drug delivery agents comprising compounds that facilitate delivery of pharmaceuticals and biotherapeutics; Drug delivery platform comprising of cellular products that facilitate delivery of pharmaceuticals and biotherapeutics; Pharmaceutical preparations for the treatment of cancers, central nervous system diseases and autoimmune disorders using compounds comprising of manipulated immune cells;

42 Research in the field of biotechnology and pharmaceutical development; Research and development of platform technologies for delivery of therapies; Research and development of platform technologies for delivery of antibody therapies, cell therapies and pharmaceuticals; Research and development regarding the use of immune system cells to discover, research and develop novel platform technologies for delivery of therapies and pharmaceuticals; Pharmaceutical research and development for the treatment of cancers, neurological diseases, and neurological disorders and autoimmune disorders; Scientific research in the field of drug delivery platforms, cell therapies and pharmaceuticals; Pharmaceutical research services; Research and development of pharmaceutical preparations for treatment of cancers, neurological diseases and disorders and autoimmune diseases; Research and development in the fields of pharmaceuticals and biotechnology; Research and development regarding the delivery of drug therapies across the blood-brain barrier and other physiological barriers; Research and development regarding the delivery of drug and cell therapies to targeted body tissue; Research and development regarding the identification and targeting of specific cells for drug therapies;

The mark consists of the word ADAPTIN in all lowercase, with an empty diagonal arrow going through the second "A" pointing toward the top right followed by the word "BIO" in all capital letters.
Color is not claimed as a feature of the mark.

Trademark Events

Sep 12, 2024

New Application Entered